Sana Biotechnology director Mary Agnes Wilderotter resigns effective Aug 29

Sana Biotechnology, Inc.

Mary Agnes Wilderotter resigned as director and chair of Nominating and Corporate Governance Committee, effective Aug 29, 2025.
She also resigned from the Audit Committee. Resignation not due to any disagreement with Sana's operations, policies, or practices.
No replacement or further board changes announced in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.